Arkolith/Insider Trading/ZYME/Form 4

Galbraith Kenneth

Chair & CEO, DirectorZymeworks Inc. (ZYME) · full profile →Form 4 · filed Jan 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2026Option exercise(M)48K—$0181K
Jan 5, 2026Sell(S)32K$25.10$795K193K
Jan 5, 2026Sell(S)23K$25.10$569K158K
Jan 5, 2026Option exercise(M)67K—$0225K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 5, 2026Option exercise(M)67K—$067K
Jan 5, 2026Option exercise(M)48K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-003097) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML